Back to search

Netherlands· NL-995a8ed47de6

ADSTILADRIN 3 × 1011 virusdeeltjes/ml intravesicale suspensie

A nadofaragene firadenovec product containing nadofarageen firadenovec, registered in Netherlands by Ferring Pharmaceuticals A/S. The same ATC class is registered in 7 of our 19 countries.

ATC L01XL10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedADSTILADRIN 3 × 1011 virusdeeltjes/ml…ATCL01XL10REGISTER NO.NL-995a8ed47de6PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Nadofaragene firadenovec is registered in 7 of 19 countries.

Countries holding a registration under ATC L01XL10 (nadofaragene firadenovec), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose

Nadofaragene firadenovec · ATC L01XL10

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
NADOFARAGEEN FIRADENOVEC
Manufacturer
Ferring Pharmaceuticals A/S
Country
Netherlands (NL)
ATC code
L01XL10
ATC class
Nadofaragene firadenovec
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/26/2035

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Nadofaragene firadenovec in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nadofaragene firadenovec products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Adstiladrin
  • Liechtenstein · Adstiladrin
  • Norway · Adstiladrin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7c4b4442-a061-4956-aa1e-3d029cb16eae
GET /v1/drugs/7c4b4442-a061-4956-aa1e-3d029cb16eae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor intravesicaal gebruik",
  "route": "Intravesicaal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/adstiladrin-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Nadofaragene firadenovec",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp134377",
  "excipients": [
    "CITROENZUUR 1-WATER (E 330)",
    "GLYCEROL (E 422)",
    "HYDROXYPROPYLBETADEX",
    "MAGNESIUMCHLORIDE 6-WATER (E 511)",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "POLYSORBAAT 80 (E 433)",
    "SACCHAROSE",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "TROMETAMOL",
    "WATER VOOR INJECTIE",
    "[N-(3-CHOLAMIDOPROPYL)-N-(3-LACTOBIONAMIDOPROPYL)]-CHOLAMIDE"
  ],
  "substances": [
    "NADOFARAGEEN FIRADENOVEC"
  ],
  "leaflet_url": null,
  "authorised_at": "2026/05/28",
  "procedure_number": "EMEA/H/C/005856",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/26/2035",
  "additional_monitoring": "Y"
}

See everything about nadofaragene firadenovec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.